APstem in the Media
We are on a mission to educate the world about the expansive potential
for advanced healing through APstem Therapeutics’ breakthrough stem cell therapy.
Publications
Treatment of Full-Thickness Skin Wounds with Blood-Derived CD34+ Precursor Cells Enhances Healing with Hair Follicle Regeneration
Advances in Wound Care
Expansion and Hepatic Differentiation of Adult Blood-Derived CD34+ Progenitor Cells and Promotion of Liver Regeneration After Acute Injury
Stem Cell Transitional Medicine
Peripheral Blood‐Derived Mesenchymal Stem Cells: Candidate Cells Responsible for Healing Critical‐Sized Calvarial Bone Defects
Stem Cell Transitional Medicine
News & Media
APstem Therapeutics Announces Successful FDA INTERACT Meeting Regarding AP-Skin-01, an “Off-the-Shelf” Allogeneic Stem Cell Product for the Treatment of Diabetic Ulcers
Leading Stanford Alumni Scientists and Physicians Launch StartX Med COVID-19 Task Force
The Funded: StartX Extends COVID-19 Demo Day
Inside the Silicon Valley ‘brain trust’ taking aim at COVID-19
Presented in 2018 JPM US-China
Healthcare Roadshow
Poster presentation in ISSCR International Symposium, Toronto 2019